- In July 2020, Weill Cornell Medicine, a leading healthcare institution, conducted a clinical trial testing stenting as a treatment for idiopathic intracranial hypertension (pseudotumor cerebri). This development aimed to evaluate the effectiveness of stent placement in patients with severe intracranial hypertension who had not responded to other treatments. The procedure is expected to provide relief by improving venous drainage, thus reducing intracranial pressure and potentially preventing vision loss and other complications. This approach is significant as it offers a novel alternative treatment for patients who are resistant to conventional therapies, benefiting those with severe forms of the condition
